Cargando…
Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach
Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries nee...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131986/ https://www.ncbi.nlm.nih.gov/pubmed/35637643 http://dx.doi.org/10.1007/s42979-022-01199-6 |
_version_ | 1784713288701968384 |
---|---|
author | Trad, Fouad El Falou, Salah |
author_facet | Trad, Fouad El Falou, Salah |
author_sort | Trad, Fouad |
collection | PubMed |
description | Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries need a way to test the effect of different distribution strategies before applying them. But how can they do this? To assist countries with this task, we built an agent-based model that runs on top of the Monte Carlo algorithm. This model simulates the spread of COVID-19 in a country where we can apply different NPIs at different times, and we can supply different kinds of vaccines using different strategies. In this study, we tested the outcomes of four vaccination strategies: older first, younger first, a mixed strategy, and a random strategy. We simulated these strategies in two different countries: France and Colombia. Then, we performed a comparative analysis to find which strategy might be the best for each country. Our results show that what is good for a country is not necessarily the best for the other one. Therefore, we proved that a vaccination strategy should be adapted to the structure of the population we are vaccinating. The system we built helps countries in this direction by allowing them to test the outcomes of their strategies before applying them in real life to select the one that minimizes human losses (deaths and infections). |
format | Online Article Text |
id | pubmed-9131986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-91319862022-05-26 Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach Trad, Fouad El Falou, Salah SN Comput Sci Original Research Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries need a way to test the effect of different distribution strategies before applying them. But how can they do this? To assist countries with this task, we built an agent-based model that runs on top of the Monte Carlo algorithm. This model simulates the spread of COVID-19 in a country where we can apply different NPIs at different times, and we can supply different kinds of vaccines using different strategies. In this study, we tested the outcomes of four vaccination strategies: older first, younger first, a mixed strategy, and a random strategy. We simulated these strategies in two different countries: France and Colombia. Then, we performed a comparative analysis to find which strategy might be the best for each country. Our results show that what is good for a country is not necessarily the best for the other one. Therefore, we proved that a vaccination strategy should be adapted to the structure of the population we are vaccinating. The system we built helps countries in this direction by allowing them to test the outcomes of their strategies before applying them in real life to select the one that minimizes human losses (deaths and infections). Springer Nature Singapore 2022-05-25 2022 /pmc/articles/PMC9131986/ /pubmed/35637643 http://dx.doi.org/10.1007/s42979-022-01199-6 Text en © The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Research Trad, Fouad El Falou, Salah Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach |
title | Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach |
title_full | Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach |
title_fullStr | Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach |
title_full_unstemmed | Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach |
title_short | Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach |
title_sort | testing different covid-19 vaccination strategies using an agent-based modeling approach |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131986/ https://www.ncbi.nlm.nih.gov/pubmed/35637643 http://dx.doi.org/10.1007/s42979-022-01199-6 |
work_keys_str_mv | AT tradfouad testingdifferentcovid19vaccinationstrategiesusinganagentbasedmodelingapproach AT elfalousalah testingdifferentcovid19vaccinationstrategiesusinganagentbasedmodelingapproach |